Clinical Trials Logo

Filter by:
NCT ID: NCT00949533 Completed - Influenza Clinical Trials

A Study on Emergence of Resistance With Tamiflu (Oseltamivir) in Patients With Seasonal Influenza

Start date: July 2009
Phase: Phase 4
Study type: Interventional

This open-label randomized 2arm study will determine the emergence of viral resistance in patients with seasonal influenza A infection treated with Tamiflu. Eligible patients </=5 years of age will be randomized to receive Tamiflu at either standard dose (30-75mg orally bid) or double dose (60-150mg orally bid) for 5 days. Target sample size is >100.

NCT ID: NCT00949468 Completed - Keratitis Clinical Trials

Microbiological Keratitis in a Countryside City of Brazil

Start date: June 2008
Phase: N/A
Study type: Observational

The purpose of this study is to identify the predisposing factors, epidemiological features and clinical and microbiological diagnosis of infectious keratitis in two public referral centers of ophthalmology in a countryside city of Brazil.

NCT ID: NCT00949442 Completed - Clinical trials for Diabetes Mellitus, Type 2

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

LANCELOT
Start date: July 2009
Phase: Phase 4
Study type: Interventional

Primary Objective: To demonstrate the superiority of insulin glargine over insulin NPH (Neutral Protamin Hagedornon) the change in HbA1c from baseline to the end of the treatment period. Secondary Objective: To compare between treatment groups: - Plasma glucose (fasting, nocturnal) over time, - Changes from baseline in HbA1c over time, - Percentage of patients who reach the target of HbA1c <7 and <6.5, - Use of prandial insulin as rescue medication at month 6, - Incidence and rate of hypoglycemia (symptomatic diurnal and nocturnal, asymptomatic and severe), - Daily dose of insulin, - Change in body weight from baseline, - Evolution of 8-point plasma-glucose (PG) profiles, - Overall safety, - Patient reported outcomes (treatment satisfaction).

NCT ID: NCT00948805 Unknown status - Infertility Clinical Trials

Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment

Start date: January 2009
Phase: Phase 3
Study type: Interventional

This study was designed to evaluate the ability of gonadotropin releasing hormone (GnRh) agonist to prevent the rise of progesterone during controlled ovarian stimulation for in vitro fertilization (IVF) after the administration of human Chorionic Gonadotropin (hCG) on the first day of menses.

NCT ID: NCT00947258 Completed - Muscle Strength Clinical Trials

Influence of Stretching on Muscle Performance

Start date: n/a
Phase: Phase 4
Study type: Interventional

The stretching is performed within sports to improve muscle performance and prevent muscle injury. However, recent studies are contradictory with common practice. Then raised the possibility that stretching before physical activity performed can decrease the muscle performance of healthy subjects.

NCT ID: NCT00946985 Terminated - Schizophrenia Clinical Trials

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Start date: June 2009
Phase: Phase 4
Study type: Interventional

The study will assess the use of paliperidone palmitate compared with oral risperidone in delaying time to relapse in patients recently diagnosed with schizophrenia who are at high risk of relapse.

NCT ID: NCT00946868 Completed - Clinical trials for Metabolic Syndrome X

Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication

Start date: May 2009
Phase: N/A
Study type: Observational

Metabolic syndrome, a group of cardiovascular risk factors related to insulin resistance, is a major determinant of cardiovascular mortality. Intermittent claudication is a symptom of an early stage of atherosclerosis. The aim of this study is to determine the prevalence of the metabolic syndrome in patients with intermittent claudication and its correlation with age, gender, localization of arterial obstruction and association with coronary artery disease.

NCT ID: NCT00946634 Completed - Clinical trials for Primary Apical Periodontite

Ozone Therapy in Endodontic Practice, in Vivo Study

Start date: January 2009
Phase: Phase 2
Study type: Interventional

The ozone therapy has been coming up as a new therapeutic modality. Medicine has been practicing since XIX century and counted great results. It is indicated for the treatment of 260 different pathologies. The researches in Dentistry has showed promising results, indicating a wide spread action in whole dental specialties. The great oxidative power of ozone provides a great antimicrobial effect and it increases the adenosine triphosphate (ATP) synthesis that can be considered as a general improvement of the cell metabolism, which can potentize the repair process. Thus, these facts justify the present study which will assess the increase of speed of apical periodontite repair.

NCT ID: NCT00944502 Not yet recruiting - Neuralgia Clinical Trials

To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins

Start date: October 2009
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and tolerability of Vitatonus Dexa compared with dexamethasone in the signs and symptoms of neuralgia of various origins. Clinical study, randomized prospective and random in nature, with a patients diagnosed with neuralgia of diverse origin. Patients will be include in sufficient quantity to achieve the minimum of 104 evaluable patients.

NCT ID: NCT00944268 Not yet recruiting - Anxiety Clinical Trials

Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety

E01ATCAL0308
Start date: September 2009
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and tolerability of the combination use of Passiflora incarnata L, Crataegus oxyacantha and Salix alba L in mild and moderate anxiety. Clinical study phase III, multicenter, prospective, open. Patients will be included in sufficient quantity to achieve the minimum number of 124 evaluable patients.